Latest Insider Transactions at Fibrogen Inc (FGEN)
This section provides a real-time view of insider transactions for Fibrogen Inc (FGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FIBROGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FIBROGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2020
|
Elias Kouchakji SVP, Clinical Dev, Drug Safety |
SELL
Payment of exercise price or tax liability
|
Direct |
2,728
-2.03%
|
$111,848
$41.99 P/Share
|
|
Dec 07
2020
|
K Peony Yu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,292
-1.65%
|
$134,972
$41.99 P/Share
|
|
Dec 01
2020
|
Mark Eisner EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+50.0%
|
-
|
|
Nov 17
2020
|
Elias Kouchakji SVP, Clinical Dev, Drug Safety |
BUY
Exercise of conversion of derivative security
|
Direct |
7,082
+5.0%
|
$99,148
$14.57 P/Share
|